Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases

BACKGROUND: To evaluate the antitumor activity and toxicity of icotinib as initial treatment in lung adenocarcinoma patients with brain metastases. METHODS: Twenty‐one patients with histologically or pathologically documented brain metastatic lung cancer were administered icotinib as initial treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jian‐ping, Liu, Xiao‐yan, Yang, Sheng, Zhang, Chang‐gong, Wang, Lin, Shi, Yuan‐kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930963/
https://www.ncbi.nlm.nih.gov/pubmed/27385986
http://dx.doi.org/10.1111/1759-7714.12351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930963/
https://www.ncbi.nlm.nih.gov/pubmed/27385986
http://dx.doi.org/10.1111/1759-7714.12351

Ejemplares similares